Wei Li

Wei Li is currently the Associate Director of New Product Planning Commercial Assessments and Forecasting at Sanofi, where they focus on forecasting for rare and oncology assets. From 2018 to 2022, they served as a Senior Manager of Business Analytics and Insights at Amgen, developing forecasting frameworks for multi-billion dollar oncology portfolios. Previously, Wei worked at ZS as a Business Consultant and Associate Consultant, where they led sales force optimization projects. Wei earned a Ph.D. in Neuroscience from UCLA, where they also conducted research related to visual processing deficits, and holds a B.S. in Computation and Neural Systems from Caltech.